Myasthenia gravis

Last updated: December 12, 2025

Myasthenia gravis

Internal Med

Internal Med

Angina pectoris
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Cardiomyopathies: Pathology review
Cardiomyopathies: Clinical
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Coronary artery disease: Clinical
Endocarditis: Pathology review
Infective endocarditis: Clinical
Valvular heart disease: Clinical
Abnormal heart sounds
Dyslipidemias: Pathology review
Hypertension: Clinical
Hypertension: Pathology review
Myocardial infarction
Myocarditis
Pericardial disease: Clinical
Pericardial disease: Pathology review
Peripheral vascular disease: Clinical
Rheumatic heart disease
Valvular heart disease: Pathology review
Peripheral artery disease
Peripheral artery disease: Pathology review
Chronic bronchitis
Asthma: Clinical
Bronchiectasis
Carcinoid syndrome
Lung cancer and mesothelioma: Pathology review
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Cor pulmonale
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Idiopathic pulmonary fibrosis
Restrictive lung diseases
Pneumonia: Pathology review
Pneumonia: Clinical
Pulmonary hypertension
Lung cancer: Clinical
Sarcoidosis
Viral hepatitis
Viral hepatitis: Clinical
Hepatitis A and Hepatitis E virus
Viral hepatitis: Pathology review
Acute pancreatitis
Chronic pancreatitis
Anal conditions: Clinical
Colorectal cancer
Colorectal cancer: Clinical
Colorectal polyps and cancer: Pathology review
Esophageal cancer
Gastric cancer
Peptic ulcers and stomach cancer: Clinical
Celiac disease
Ascending cholangitis
Primary sclerosing cholangitis
Gallbladder disorders: Pathology review
Gallbladder disorders: Clinical
Acute cholecystitis
Chronic cholecystitis
Gallstones
Cirrhosis: Clinical
Ulcerative colitis
Crohn disease
Inflammatory bowel disease: Clinical
Diverticular disease: Clinical
Diverticular disease: Pathology review
Esophageal disorders: Clinical
Esophageal disorders: Pathology review
Esophagitis: Clinical
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastroesophageal reflux disease (GERD): Clinical
Gastrointestinal bleeding: Clinical
Gastrointestinal bleeding: Pathology review
Hepatocellular carcinoma
Abdominal hernias
Hernias: Clinical
Irritable bowel syndrome
Peptic ulcer
Inflammatory bowel disease: Pathology review
Fibromyalgia
Gout and pseudogout: Pathology review
Vasculitis: Clinical
Polymyalgia rheumatica
Polymyositis
Myalgias and myositis: Pathology review
Reactive arthritis
Rheumatoid arthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Sjogren syndrome: Clinical
Systemic lupus erythematosus (SLE): Clinical
Scleroderma: Pathology review
Acromegaly
Adrenal insufficiency: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Cushing syndrome: Clinical
Diabetes insipidus
Diabetes mellitus: Clinical
Hypercalcemia
Hypocalcemia
Electrolyte disturbances: Pathology review
Hypernatremia
Hyponatremia
Hyperparathyroidism
Hypoparathyroidism
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Hashimoto thyroiditis
Riedel thyroiditis
Paget disease of bone
Pheochromocytoma
Pituitary adenomas and pituitary hyperfunction: Clinical
Pituitary tumors: Pathology review
Thyroid nodules and thyroid cancer: Clinical
Bell palsy
Cerebral palsy
Aneurysms
Cerebral vascular disease: Pathology review
Stroke: Clinical
Headaches: Clinical
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Delirium
Dementia and delirium: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Hyperkinetic movement disorders: Clinical
Guillain-Barre syndrome
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Muscle weakness: Clinical
Parkinson disease
Hypokinetic movement disorders: Clinical
Seizures: Clinical
Syncope: Clinical
Ischemic stroke
Acid-base disturbances: Pathology review
Renal failure: Pathology review
Acute kidney injury: Clinical
Prostate disorders and cancer: Pathology review
Benign prostatic hyperplasia
Non-urothelial bladder cancers
Erectile dysfunction
Nephritic and nephrotic syndromes: Clinical
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Testicular tumors: Pathology review
Hydronephrosis
Polycystic kidney disease
Prostate cancer
Acute pyelonephritis
Chronic pyelonephritis
Urinary tract infections: Clinical
Kidney stones: Clinical
Renal cell carcinoma
Renal artery stenosis
Renal and urinary tract masses: Pathology review
Abdominal pain: Clinical
Primary adrenal insufficiency
Adrenal insufficiency: Clinical
Glaucoma
Acute respiratory distress syndrome: Clinical
Advanced cardiac life support (ACLS): Clinical
Heart blocks: Pathology review
Cardiac tamponade
Miscellaneous hypoglycemics
Hypertension
ECG cardiac infarction and ischemia
Small bowel ischemia and infarction
Pericarditis and pericardial effusion
Pneumothorax
Pneumothorax: Clinical
Pulmonary embolism
Seizures: Pathology review
Shock
Shock: Clinical
Seizures and epilepsy
Thyroid storm
Acute leukemia
Chronic leukemia
Anemia of chronic disease
Platelet disorders: Pathology review
Coagulation disorders: Pathology review
Bleeding disorders: Clinical
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Thrombosis syndromes (hypercoagulability): Pathology review
Immune thrombocytopenia
Iron deficiency anemia
Lymphoma: Clinical
Plasma cell disorders: Clinical
Sickle cell disease: Clinical
Alpha-thalassemia
Beta-thalassemia
Thrombotic thrombocytopenic purpura
Vitamin B12 deficiency
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Anemia: Clinical
Clostridium botulinum (Botulism)
Candida
Chlamydia pneumoniae
Chlamydia trachomatis
Vibrio cholerae (Cholera)
Central nervous system infections: Pathology review
Congenital cytomegalovirus (NORD)
Corynebacterium diphtheriae (Diphtheria)
Epstein-Barr virus (Infectious mononucleosis)
Neisseria gonorrhoeae
Herpes simplex virus
Fever of unknown origin: Clinical
Pneumonia
HIV and AIDS: Pathology review
HIV (AIDS)
Influenza virus
Borrelia burgdorferi (Lyme disease)
Lyme Disease
Diarrhea: Clinical
Bordetella pertussis (Whooping cough)
Rabies virus
Rickettsia rickettsii (Rocky Mountain spotted fever) and other Rickettsia species
Salmonellosis
Shigella
Treponema pallidum (Syphilis)
Clostridium tetani (Tetanus)
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Varicella zoster virus

Flashcards

Myasthenia gravis

0 of 12 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 5 complete

Start
A 40-year-old woman begins complaining of dyspnea while recovering in the post-anesthesia care unit. Earlier in the day, the patient underwent a laparoscopic cholecystectomy for treatment of symptomatic gallstones. Past medical history is unremarkable. Her temperature is 37.7°C (99.9°F), pulse is 93/min, respiratory rate is 24/min and blood pressure is 125/72 mmHg. Physical examination shows the patient in distress with shallow breaths, using accessory muscles. In addition, the patient is observed to have drooping of the eyelids and corners of the mouth bilaterally. Pupils are 3 cm bilaterally and reactive to light. An arterial blood gas measurement reveals the following findings:  

 Laboratory Value  Result  Reference Range 
 pH  7.31  7.35-7.45 
 PaCO2  56 mmHg  33-45 mmHg 
 PaO2  71 mmHg  75-105 mmHg 
 Bicarbonate  25 mmol/L  22-28 mmol/L 
   
The patient’s condition improves with administration of edrophonium chloride. Which of the following best describes the cause of this patient’s condition? 

Transcript

Watch video only

Myasthenia gravis comes from the Greek word ‘myasthenia’, meaning muscle weakness; and the Latin word ‘gravis’, meaning severe. So, myasthenia gravis is an autoimmune condition that causes serious muscle weakness.

First, let's focus on physiology and how muscles normally work. Whether you’re reaching for a slice of pizza or sinking that perfect shot in basketball, it all starts in the brain. The upper motor neuron of the cerebral cortex fires an action potential down the spinal cord to activate lower motor neurons. Next, lower motor neurons pick up these signals and pass them along their axons toward terminal branches and axon terminals, all the way to skeletal muscle fibers.

This communication site between the lower motor neuron and the skeletal muscle fiber is known as the neuromuscular junction, which consists of three main parts. First, there’s the presynaptic membrane, which is the axon terminal of the lower motor neuron packed with acetylcholine vesicles. Acetylcholine is actually the neurotransmitter that enables muscle contraction. Next, there’s the postsynaptic membrane, which is the membrane of the skeletal muscle fiber, rich in nicotinic acetylcholine receptors.

Finally, this tiny space between two membranes is called the synaptic cleft and contains the enzyme acetylcholine esterase.

Now, the arrival of the action potential at the axon terminal triggers the opening of voltage-gated calcium channels in the presynaptic membrane, allowing calcium ions to rush in. This triggers the acetylcholine vesicles to fuse with the presynaptic membrane and release acetylcholine into the synaptic cleft. Once inside the cleft, acetylcholine moves across to bind nicotinic acetylcholine receptors on the postsynaptic membrane. Eventually, this binding triggers the muscle cell to depolarize, setting off a chain of intracellular events that lead to contraction. Once the contraction is over, acetylcholine is broken down by acetylcholine esterase, allowing the muscle to relax and prepare for the next signal.

In myasthenia gravis, the immune system produces antibodies that disrupt the normal function of nicotinic acetylcholine receptors. Now, there are three types of autoantibodies. First, we have blocking antibodies, which bind and block acetylcholine receptors, so acetylcholine can’t activate them. Next, there are binding antibodies, which bind the receptors and activate the complement system, eventually destroying them. Finally, the third type includes modulating antibodies, which bind the receptors and trigger the muscle cell to pull the entire receptor inside.

As more receptors are blocked, destroyed, or removed from the postsynaptic membrane, it becomes harder for muscles to receive signals, leading to muscle weakness.

But that's not all. Sometimes, the immune system does not directly attack the acetylcholine receptors. Instead, it targets other important proteins that help neuromuscular junctions work properly, like Muscle Specific Kinase and Lipoprotein Related Protein 4. When they are disrupted, the connection between nerves and muscles becomes unstable or weak, making it even harder for signals to reach the muscle and causing further muscle weakness.

Now, several risk factors contribute to myasthenia gravis, including thymic abnormalities and genetics. In thymic hyperplasia, the thymus enlarges and forms reactive B-cell follicles that produce autoantibodies. Next up is thymoma, which is a tumor that arises from the epithelial cells of the thymus. Both conditions can cause the thymus to misguide the immune system into attacking acetylcholine receptors.

Next up are genetic factors. Certain HLA subtypes, which are genes that help control the immune system, can make someone more likely to develop autoimmune conditions like myasthenia gravis. Moreover, myasthenia gravis often shows up alongside other autoimmune diseases, such as thyroiditis, lupus, or rheumatoid arthritis.

Now, moving to clinical manifestations. As the immune system blocks, destroys or removes receptors from the postsynaptic membrane, muscles have a hard time receiving signals. Ultimately this leads to muscle weakness and fatigue, which is more pronounced in the proximal muscles.

Remember when you were a kid and spent the whole day in the backyard shooting basketballs? Imagine that after a few throws your muscles start to feel weak. You’d have to stop and rest before you could keep playing. Well, that’s what it’s like for someone with myasthenia gravis. Their muscles get tired quickly, even with simple things like brushing their teeth or combing their hair.

Key Takeaways

Myasthenia gravis is an autoimmune disease, specifically a type II hypersensitivity disorder, which is characterized by autoantibodies against nicotinic acetylcholine receptors on the surface of muscle cells.

The antibodies block the receptors which means the signal to contract isn't received. Those antibodies also activate the complement pathway which leads to muscle cell destruction.

Symptoms can range from mild to severe and may include drooping eyelids, difficulty speaking or swallowing, and muscle weakness in the arms and legs. Treatment involves immunosuppressive drugs like prednisolone, and acetylcholinesterase inhibitors like neostigmine. The purpose is to reduce the immune system's attack on the muscle and to increase muscle strength.

Sources

  1. "Robbins & Kumar Basic Pathology. Available from: ClinicalKey Student, (11th Edition). " Elsevier Limited (UK) (2022. Page 718-720 )
  2. "Conn's Current Therapy 2025. Available from: ClinicalKey Student" Elsevier Limited (UK) (2024. Page 806-811 )
  3. "Crush Step 1 E-Book. Available from: ClinicalKey Student, (3rd Edition)" Elsevier Limited (UK) (2023. Page 461-471 )